Compounded Drugs: Payment Practices Vary across Public Programs and Private Insurers, and Medicare Part B Policy Should Be Clarified

Home > Diane Publishing Books >

Our Price: $20.00

By John Dicken (au)
Year: 2014
Pages: 40
Binding Paperback
ISBN 978-1-4578-5897-0

Product Code: 1457858975

Description

Drug compounding is a process whereby a pharmacist mixes or alters ingredients to create a drug tailored to the medical needs of an individual patient. Compounded drugs make up 1 to 3 percent of the $300 billion domestic prescription drug market. Compounded drugs and some of their ingredients are not approved by the Food and Drug Administration (FDA). Members of Congress have questioned whether federal health care programs' payment practices create incentives for providers to prescribe these drugs. This report examined (1) Medicare's, Medicaid's, and private health insurers' payment practices for compounded drugs; and (2) the extent to which these payment practices for compounded drugs affect their use. Figures. This is a print on demand report.

Share your knowledge of this product with other customers... Be the first to write a review